Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Welgen is a biotechnology company specializing in the design and production of high-quality viral vectors for gene delivery and gene expression studies. Based in Worcester, Massachusetts, the company provides a comprehensive suite of services including the construction and packaging of Adenovirus, Lentivirus, Adeno-associated virus (AAV), and Retrovirus. Welgen supports academic and pharmaceutical researchers by offering custom shRNA and miRNA expression vectors, as well as purified, high-titer viral stocks for in vitro and in vivo applications. Their expertise facilitates advanced research in functional genomics, drug discovery, and gene therapy development. The company is recognized for its rapid turnaround times and technical support in optimizing viral delivery systems for specific research needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Welgen.